The molecular biology revolution and the rise of bioscience megacentres in North America and Europe

被引:32
作者
Cooke, P [1 ]
机构
[1] Univ Cardiff Wales, Ctr Adv Studies, Cardiff CF10 3BB, Wales
[2] Univ Cardiff Wales, ESRC, Ctr Social & Econ Anal Genom, Cardiff CF10 3BB, Wales
来源
ENVIRONMENT AND PLANNING C-GOVERNMENT AND POLICY | 2004年 / 22卷 / 02期
关键词
D O I
10.1068/c0344
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This paper focuses on 'triple helix' effects in biosciences. Scientific change can have profound socioeconomic effects. The molecular biology revolution tilted pharmaceuticals production away from its fine chemistry path dependence into microbiology and biotechnology. The key to any triple helix effects has thus shifted to universities and spinouts buttressed with burgeoning public funding, leaving 'big pharma' increasingly playing the role of licenser and marketer of bought-in therapeutic treatments. Concentration in the healthcare value chain means a few places that have become bioscience 'megacentres' dominate healthcare innovation. Ambitious regions seeking to establish megacentres of their own are causing governments to experiment with 'regional science policy' to build up competitiveness.
引用
收藏
页码:161 / 177
页数:17
相关论文
共 29 条
[1]  
ANDERMANN A, 1996, PHYS FADS PHARM HIST
[2]  
[Anonymous], 2001, RETHINKING SCI
[3]  
COE J, 2002, NETWORKED PHARMA INN
[4]  
COOKE P, 2004, IN PRESS EUROPEAN PL
[5]  
COOKE P, 2002, IN PRESS CAMBR J EC
[6]  
COOKE P, 2002, CLUST OLD NEW
[7]  
COOKE P, 2002, INT WORKSH KNOWL SPI
[8]  
Cooke P, 2002, KNOWLEDGE EC
[9]  
Cooke P., 2000, Z. Wirtsch, V44, P246, DOI [10.1515/zfw.2000.0017, DOI 10.1515/ZFW.2000.0017]
[10]  
Cortright Joseph., 2002, SIGNS LIFE GROWTH BI